Cite
MLA Citation
Silvia Kruppert et al.. “S1041 Treatment Patterns of an Adalimumab Biosimilar (ABP 501) Among Patients With Inflammatory Bowel Disease: An Observational Study Using German Pharmacy Claims Database.” American journal of gastroenterology, vol. 117, n.d., pp. e754–e755. http://access.bl.uk/ark:/81055/vdc_100169532343.0x00003a